Search the Newsreel

Valvoline faces earnings test as base oil shortage reshapes market By Investing.com

Valvoline Inc. is set to report its fiscal third-quarter earnings, with analysts anticipating strong growth despite an industry-wide base oil shortage. The company is expected to leverage this supply disruption to accelerate market share gains, driven by rising wholesale motor oil prices and strategic …

Boston Partners (VVV) reports 5.17% beneficial stake in Valvoline common stock

Boston Partners has disclosed a 5.17% beneficial ownership stake in Valvoline Inc. common stock, totaling 6,597,960 shares as of June 30, 2026. The firm holds sole voting power over 6,227,151 shares and sole dispositive power over all 6,597,960 shares, primarily for discretionary client accounts. …

LiveOne (Nasdaq: LVO) to Report First Quarter Fiscal 2027 Financial Results on August 12, 2026

LiveOne (Nasdaq: LVO) announced it will report its first quarter fiscal 2027 financial results on August 12, 2026. The company expects to report continued year-over-year growth in revenue and Adjusted EBITDA, driven by organic growth, balance sheet strengthening, and strategic capital allocation. Management will …

ALVO|Alvotech SA|Price:3.785|Chg%:-0.335

Alvotech SA (ALVO) has a relatively weak fundamental profile but high growth potential, with its valuation considered fairly valued within the Biotechnology & Medical Research industry. Institutional ownership is very high, and analysts have recently rated it as a "Buy" with a target price …

Blue Ops Integrates Volvo Penta D4-320 Propulsion System into Variant 7 Uncrewed Surface Vessel

Red Cat Holdings, Inc. First Volvo Penta-powered Variant 7 pairs proven marine propulsion with Blue Ops' production-ready autonomous maritime platform SALT LAKE CITY, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of …

Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31

This article provides the Nordic Life Science Weekly Report for Week 31, 2026, offering key insights into the market, major events, financial impact, development and research, and a catalyst watch. It highlights that Novo Nordisk missed expectations, AstraZeneca remained stable, and Alvotech received FDA …

Alvo Minerals Boosts Brazilian Critical Minerals Push with Touro Drilling and Government-Backed Survey

Price to earnings forward of Valvoline, Inc. – BX:0V4

This page from TradingView provides financial information for Valvoline, Inc. (BX:0V4), specifically focusing on its forward price-to-earnings ratio. The content indicates that the market is currently closed with no trades recorded.

Enterprise value to EBIT forward of Valvoline, Inc. – BX:0V4

This article displays the "Enterprise value to EBIT forward" metric for Valvoline, Inc. (BX:0V4) on the TradingView platform. It shows that the market for this stock is currently closed with no trades. The primary content is a single data point within a financial overview.

LiveOne (NASDAQ:LVO) Stock Rating Upgraded by Wall Street Zen

LiveOne (NASDAQ:LVO) received an upgraded stock rating from Wall Street Zen, moving from "sell" to "hold," aligning with the broader analyst consensus of "Hold" and a $12.50 price target. Despite the upgrade, LiveOne reported a quarterly loss of $0.65 per share and revenue of …

Alvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs Advance - Has The Bull Case Changed?

Alvotech (ALVO) stock rose 34.6% after the FDA cleared its Reykjavik manufacturing plant with a Voluntary Action Indicated classification, addressing previous observations and allowing the company to advance multiple Biologics License Applications (BLAs) in the US. This regulatory progress, along with the acceptance of …

Valvoline (VVV) Appoints Katherine Fogertey And Scott Mezvinsky To Its Board

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Valvoline (NYSE:VVV) has appointed Katherine Fogertey and Scott Mezvinsky to its Board of Directors. The two executives bring experience in finance, restaurant industry transformation, and …

Form 424B5 LiveOne Inc For: 30 July By Investing.com

This article announces the filing of Form 424B5 by LiveOne Inc. for July 30, 2026. The content is brief, primarily serving as a notification of the regulatory filing and is published by Investing.com. It does not provide further details regarding the contents of the …

LiveOne Inc (LVO) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of LiveOne Inc (LVO), highlighting its weak financial status and average operating efficiency. The company's current financial score is 6.20, ranking low within the Media & Publishing industry. LiveOne Inc reported a year-over-year decrease in both quarterly revenue …

Valvoline Inc. Releases Fiscal 2025 Impact Report Highlighting Progress in People, Communities and Environmental Stewardship

Valvoline Inc. has released its Fiscal 2025 Impact Report, detailing significant progress in areas such as employee support, community engagement, and environmental efforts. Key achievements include raising a record $1.8 million for Children’s Miracle Network, investing over $1.4 million in service center upgrades, and …

Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages

Alvotech (NASDAQ:ALVO) has received a consensus "Hold" rating from six brokerages, with an average 12-month price target of $7.60, significantly higher than its current share price of $3.53. Institutional investors like ProShare Advisors and Mirae Asset Global Investments have increased their stakes, while the …

Piper Sandler reiterates Valvoline stock rating on solid quarter outlook

Piper Sandler has reiterated an Overweight rating and a $44.00 price target for Valvoline (NYSE: VVV), predicting an 11% upside from its current trading price. The firm anticipates Valvoline will exceed estimates and raise guidance for its fiscal third quarter results, scheduled for August …

Alvotech Shares Rise After Wrapping FDA Facility Inspection

Alvotech's shares increased following the successful completion of a U.S. FDA facility inspection related to its a new biosimilar project, AVT02. The company received some observations but stated they are not expected to impact the timeline for its Humira biosimilar. This marks a significant …

VVV|Valvoline Inc|Price:39.296|Chg%:-0.354

This article provides a comprehensive stock analysis of Valvoline Inc (VVV) from TradingKey. It highlights the company's stable fundamentals, high growth potential, and fair valuation within the Personal & Household Products & Services industry. The analysis includes key insights, score breakdown, strengths like revenue …

Valvoline Inc. (VVV) Stock Forecasts

Argus has raised its target price for Valvoline Inc. (VVV) to $42.00, up from its previous target. Valvoline, a consumer cyclical company, produces and markets automotive maintenance products, primarily lubricants, to various customers. The current stock price for VVV is $39.65.

Is Valvoline’s (VVV) Board Adding Consumer Veterans Altering The Investment Case For Valvoline?

Valvoline Inc. has enhanced its Board of Directors by appointing Katherine Fogertey (former Shake Shack CFO) and Scott Mezvinsky (CEO of Yum! Brands’ KFC division), signaling a stronger focus on operational discipline, brand growth, and board oversight. While these additions bring significant consumer and …

US FDA Closes Inspection of Alvotech's Manufacturing Facility in Iceland

Alvotech has announced the successful conclusion of a U.S. FDA inspection of its manufacturing facility in Reykjavik, Iceland, with no Form 483s issued. This positive outcome is a significant step for the company, as it addresses previous issues that had prevented the approval of …

LiveOne, Inc. (NASDAQ:LVO) Sees Large Decline in Short Interest

LiveOne, Inc. (NASDAQ:LVO) experienced a significant 42.1% decrease in short interest, bringing the total to 121,186 shares as of July 15th. This represents 1.2% of shares outstanding and a 3.3 days-to-cover ratio. The stock declined by 5.9% to $4.50 after the company reported a …

Valvoline Q3 Same-Store Sales Expected to Beat Estimates, RBC Says

RBC analysts predict Valvoline's Q3 same-store sales will surpass estimates. The article highlights recent company news, analyst ratings, and an overview of Valvoline's business, which focuses on automotive preventive maintenance services through its franchised and company-operated service centers.

Alvotech (NASDAQ:ALVO) Shares Up 13.5% - Here's What Happened

Alvotech (NASDAQ:ALVO) saw its shares climb 13.5% in mid-day trading but with significantly reduced volume. Analyst sentiment is mixed, with an average "Hold" rating and a target price of $7.60, as the company continues to report negative profitability despite $105.9 million in quarterly revenue. …

Alvotech Marks Key Milestone As FDA Closes Inspection Of Reykjavik Facility; Stock Up

(RTTNews) - Alvotech (ALVO), a biotechnology company focused on developing and manufacturing biosimilar medicines, announced that the U.S. FDA has successfully closed its inspection of the company's manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA classified the site as Voluntary Action …

FDA closes Alvotech (NASDAQ: ALVO) Iceland plant inspection with VAI status

Alvotech (NASDAQ: ALVO) announced that the U.S. FDA has closed its May 2026 inspection of its Reykjavik, Iceland manufacturing facility with a Voluntary Action Indicated (VAI) classification. The company views this as a significant milestone, reflecting enhanced quality systems and manufacturing operations. Alvotech continues …

Alvotech clears FDA inspection of Iceland manufacturing site, advancing biosimilar drug approvals.

Alvotech announced the successful closure of an FDA inspection at its manufacturing facility in Reykjavik, Iceland, which was classified as Voluntary Action Indicated (VAI). This clearance is a crucial step for Alvotech, allowing the company to advance its biosimilar drug pipeline. The company is …

Alvotech works toward FDA approval for three biosimilar applications

Alvotech announced that the FDA has closed its May 2026 inspection of the company's Reykjavik manufacturing facility with a Voluntary Action Indicated (VAI) classification, indicating concerns that the firm is asked to address voluntarily. This positive outcome reflects the company's efforts to strengthen quality …

Alvotech announces successful closure of FDA inspection of manufacturing facility

Alvotech announced the successful closure of an FDA inspection of its Reykjavik, Iceland manufacturing facility, with the FDA classifying the site as Voluntary Action Indicated (VAI). This is a significant milestone for Alvotech, demonstrating strengthened quality systems and manufacturing operations. The company is confident …

Valvoline (VVV) to Release Quarterly Earnings on Wednesday

Valvoline's Fast Growth Opens The Path To Slick Upside

Valvoline (NYSE:VVV) - Stock Analysis

This article provides a detailed stock analysis of Valvoline (NYSE:VVV), covering its market performance, financial health, growth prospects, and recent news. Key highlights include an analyst consensus target indicating the stock is undervalued, significant earnings growth forecasts, and recent executive appointments. The analysis also …

LiveOne Inc (LVO) Cash Flow

This article provides a detailed cash flow statement for LiveOne Inc (LVO), including quarterly and annual data for operating, investing, and financing activities. It also defines key cash flow terms and offers answers to frequently asked questions regarding LVO's financial performance in these areas. …

LiveOne Issues 70,000 Shares at $7.50 to Music Story, Extends Metadata License to 2028

LiveOne (LVO) has entered into an agreement with Music Story to settle outstanding fees and prepay future fees by issuing 70,000 common shares at $7.50 per share. This agreement also extends their metadata license through February 24, 2028, and includes restrictions on Music Story's …

Valvoline Inc (VVV) Q2 2023 Earnings Report - Results, Call & Slides

This article provides details on Valvoline Inc's (VVV) Q2 2023 earnings report. The company beat EPS expectations at $0.23 against a consensus of $0.22, but missed revenue forecasts, reporting $344.50M against an expected $347.48M. The report also includes historical earnings data and future estimated …